PDCD1 and acute myeloid leukemia: As previously reported in the literature for some cancer types [40,41], the co-inhibitory receptor PD-1 and the ectonucleotidase CD73 were expressed by NK cells but at low levels without a significant difference between the AML and HD cohorts (Figure 2C).